ECOG PCO-RL: E1505: A Phase III Randomized Trial of Adjuvant Chemotherapy With or Without Bevacizumab for Patients with Completely Resected Stage IB (>4cm)-IIIA Non-Small Cell Lung Cancer

Project: Research project

Project Details

StatusFinished
Effective start/end date6/1/0712/31/12

Funding

  • Frontier Science and Technology Research Foundation (PCOE1505-00/E1505)
  • Genentech, Inc. (PCOE1505-00/E1505)